Key Events This Week
4 May: Valuation shifts highlight price attractiveness challenges
5 May: Technical momentum shifts amid mixed indicator signals
8 May: Week closes at ₹952.10 (-0.07%) vs Sensex +1.25%
May 11
BSE+NSE Vol: 29.34 lacs

Fortis Healthcare Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance against its sector and the broader Sensex, coupled with rising volumes and positive price action, suggests a shift in investor sentiment towards a more bullish stance despite a recent downgrade in its Mojo Grade to Sell.
Read full news article
4 May: Valuation shifts highlight price attractiveness challenges
5 May: Technical momentum shifts amid mixed indicator signals
8 May: Week closes at ₹952.10 (-0.07%) vs Sensex +1.25%

Fortis Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a 3.18% gain on 5 May 2026, the stock’s technical landscape remains nuanced, warranting a detailed analysis for investors navigating the hospital sector’s mid-cap space.
Read full news article
Fortis Healthcare Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting evolving market perceptions and price attractiveness. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with historical averages and peer benchmarks, and assesses the implications for investors amid the hospital sector’s broader context.
Read full news article
Fortis Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
27 Apr: Sharp open interest surge amid sustained price gains (₹953.65, +2.75%)
28 Apr: Slight price dip with mixed technical signals (₹952.95, -0.07%)
29 Apr: Technical momentum shifts to sideways trend (₹934.60, -1.93%)
30 Apr: Mildly bearish technical stance emerges; price closes at ₹923.35 (-1.20%)

Fortis Healthcare Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex interplay of momentum and trend factors for this mid-cap hospital sector stock.
Read full news article
Fortis Healthcare Ltd (NSE: 970940) has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a marginal day decline of 0.07%, the stock’s technical indicators present a complex picture, with weekly signals showing bullish tendencies while monthly metrics remain cautiously bearish. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on Fortis’s near-term prospects within the hospital sector.
Read full news article
Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, coinciding with a robust price rally and sustained volume activity. The stock’s recent outperformance relative to its sector and the broader market highlights evolving market positioning and potential directional bets by investors.
Read full news articleFortis Healthcare Limited has informed the Exchange regarding 'Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI LODR")'.
Fortis Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Mr. Sim Heng Joo Joe (DIN:08033111) ( Mr. Joe ) as an additional director (Non-Executive and Non-Independent) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. He is not related to any of the existing directors. Brief Profile of Mr. Joe is attached herewith.
Fortis Healthcare Limited has informed the Exchange regarding a press release dated November 18, 2019, titled "Intimation under Regulation 30 Press Release".
No Upcoming Board Meetings
Fortis Healthcare Ltd has declared 10% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
Fortis Healthcare Ltd has announced 2:5 rights issue, ex-date: 18 Aug 09